Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood
Juvenile dermatomyositis, the most common inflammatory myopathy of childhood, is a rare
systemic autoimmune vasculopathy that is characterised by weakness in proximal muscles …
systemic autoimmune vasculopathy that is characterised by weakness in proximal muscles …
Idiopathic inflammatory myopathies: clinical approach and management
Idiopathic inflammatory myopathies (IIM) are a group of chronic, autoimmune conditions
affecting primarily the proximal muscles. The most common types are dermatomyositis (DM) …
affecting primarily the proximal muscles. The most common types are dermatomyositis (DM) …
Rituximab in the treatment of inflammatory myopathies: a review
Several uncontrolled studies have encouraged the use of rituximab (RTX) in patients with
myositis. Unfortunately, the first placebo-phase trial to assess the efficacy of RTX in …
myositis. Unfortunately, the first placebo-phase trial to assess the efficacy of RTX in …
Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care
C Papadopoulou, C Chew, MGL Wilkinson… - Nature Reviews …, 2023 - nature.com
The childhood-onset or juvenile idiopathic inflammatory myopathies (JIIMs) are a
heterogenous group of rare and serious autoimmune diseases of children and young …
heterogenous group of rare and serious autoimmune diseases of children and young …
Juvenile dermatomyositis. Where are we now?
Juvenile onset idiopathic inflammatory myopathy (IIM) has many similarities and distinct
differences from adult-onset disease. This review will focus on recent developments in …
differences from adult-onset disease. This review will focus on recent developments in …
Cutaneous improvement in refractory adult and juvenile dermatomyositis after treatment with rituximab
R Aggarwal, P Loganathan, D Koontz, Z Qi… - …, 2017 - academic.oup.com
Objective. The aim was to assess the efficacy of rituximab for the cutaneous manifestations
of adult DM and JDM. Methods. Patients with refractory adult DM (n= 72) and JDM (n= 48) …
of adult DM and JDM. Methods. Patients with refractory adult DM (n= 72) and JDM (n= 48) …
Evaluation and treatment of inflammatory myopathies
The major types of idiopathic inflammatory myopathy include dermatomyositis (DM),
polymyositis (PM), inclusion body myositis (IBM) and immune mediated necrotising …
polymyositis (PM), inclusion body myositis (IBM) and immune mediated necrotising …
Classification, diagnosis, and management of idiopathic inflammatory myopathies
IN Lazarou, PA Guerne - The journal of Rheumatology, 2013 - jrheum.org
The detection and characterization of a large array of autoantibodies, including at least 8
different antisynthetase, anti-SRP,-200/100 (HMGCR),-Mi-2,-CADM-140 (MDA5),-SAE …
different antisynthetase, anti-SRP,-200/100 (HMGCR),-Mi-2,-CADM-140 (MDA5),-SAE …
Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists
H Kohsaka, T Mimori, T Kanda, J Shimizu… - Modern …, 2019 - academic.oup.com
Although rheumatologists, neurologists and dermatologists see patients with polymyositis
(PM) and dermatomyositis (DM), their management appears to vary depending on the …
(PM) and dermatomyositis (DM), their management appears to vary depending on the …
Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment
LR Wedderburn, LG Rider - Best practice & research Clinical rheumatology, 2009 - Elsevier
Juvenile dermatomyositis (JDM) is a rare, potentially life-threatening systemic autoimmune
disease primarily affecting muscle and skin. Recent advances in the recognition …
disease primarily affecting muscle and skin. Recent advances in the recognition …